Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12959-015-0047-z http://scihub22266oqcxt.onion/10.1186/s12959-015-0047-z C4399148!4399148!25883536     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25883536&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Thromb+J 2015 ; 13 (ä): ä Nephropedia Template TP {{tp|p=25883536|t=2015. Thrombosis in vasculitis: from pathogenesis to treatment |pdf=|usr=}}{{25883536}} gab.com Text Thrombosis in vasculitis: from pathogenesis to treatment JO: Thromb J http://www.kidney.de/pget.php?&tw=1&pmid=25883536 #FOAvip In recent years, the relationship between inflammation and thrombosis has been deeply investigated and it is now clear that immune and coagulation systems are functionally interconnected.Inflammation-induced thrombosis is by now considered a feature not only of autoimmune rheumatic diseases, but also of systemic vasculitides such as Behçet?s syndrome, ANCA-associated vasculitis or giant cells arteritis, especially during active disease.These findings have important consequences in terms of management and treatment. Indeed, Behçet?syndrome requires immunosuppressive agents for vascular involvement rather than anticoagulation or antiplatelet therapy, and it is conceivable that also in ANCA-associated vasculitis or large vessel-vasculitis an aggressive anti-inflammatory treatment during active disease could reduce the risk of thrombotic events in early stages.In this review we discuss thrombosis in vasculitides, especially in Behçet?s syndrome, ANCA-associated vasculitis and large-vessel vasculitis, and provide pathogenetic and clinical clues for the different specialists involved in the care of these patients. Twit Text FOAVip Thrombosis in vasculitis: from pathogenesis to treatment ????Thromb J http://www.kidney.de/pget.php?&tw=1&pmid=25883536 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25883536 #FOAvip English Wikipedia <ref>{{Cite pmid|25883536}}</ref> Thrombosis in vasculitis: from pathogenesis to treatment #MMPMID25883536 Emmi G; Silvestri E; Squatrito D; Amedei A; Niccolai E; D?Elios MM; Della Bella C; Grassi A; Becatti M; Fiorillo C; Emmi L; Vaglio A; Prisco D Thromb J 2015[]; 13 (ä): ä PMID25883536show ga In recent years, the relationship between inflammation and thrombosis has been deeply investigated and it is now clear that immune and coagulation systems are functionally interconnected.Inflammation-induced thrombosis is by now considered a feature not only of autoimmune rheumatic diseases, but also of systemic vasculitides such as Behçet?s syndrome, ANCA-associated vasculitis or giant cells arteritis, especially during active disease.These findings have important consequences in terms of management and treatment. Indeed, Behçet?syndrome requires immunosuppressive agents for vascular involvement rather than anticoagulation or antiplatelet therapy, and it is conceivable that also in ANCA-associated vasculitis or large vessel-vasculitis an aggressive anti-inflammatory treatment during active disease could reduce the risk of thrombotic events in early stages.In this review we discuss thrombosis in vasculitides, especially in Behçet?s syndrome, ANCA-associated vasculitis and large-vessel vasculitis, and provide pathogenetic and clinical clues for the different specialists involved in the care of these patients. äThrombosis in vasculitis: from pathogenesis to treatment (epmc).pdf DeepDyve Pubget Overpricing